Bing

SEARCH HISTORY

An example of this kind of little known stock is 3Sbio Inc. (NASDAQ: SSRX), a Chinese biotechnology company that trades on the Nasdaq. Shares of SSRX had begun to sell off at the end of March after rallying to new highs. But within two days of of those ...
Trading Markets · ByDavid Penn · 6/22/2015
On Tuesday, 3SBio Inc. fell 0.34% to $13.3 for a market cap of $293.70 million, but the stock is up 30.4% over the past year and up 16.4% over the past five years. EastBridge Investment Group Corp (PINK: EBIG) Is Getting Into the Chinese Stem Cell …
Smallcap Network · ByJohn Udovich · 1/23/2013
Explore the tool here. Article printed from InvestorPlace Media, http://investorplace.com/2013/02/4-biotechnology-stocks-to-buy-now-kerx-astx-ssrx/.
Investor Place · 2/6/2013
More from Bing News
The revenue growth greatly exceeded the industry average of 3.0%. Since the same quarter one year prior, revenues rose by 33.7%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share. SSRX
The Street · 3/13/2012
The compelling valuation metrics, the strong growth prospects, the analysts' recommendation and the fact that the SSRX stock is in an uptrend; all these factors make the SSRX stock quite attractive. Volterra Semiconductor Corporation engages in the …
Seeking Alpha · ByArie Goren · 12/7/2012
3SBio Inc. (NASDAQ:SSRX) is another stock with limited downside risk from here on. ChinaCast Education (NASDAQ:CAST) is another stock with significant loss of momentum - but more downside is possible, according to the oversold chart. Ata Inc.
China Vestor · 3/2/2011
Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List today: 3SBio Inc. (:ADR) (SSRX) AdCare Health Systems, Inc. (ADK) Altera Corp. (ALTR) Antares Pharma Inc. (ATRS) AptarGroup, Inc. (ATR) View the entire Zacks #5 Rank List. 3SBIO …
Yahoo Finance · 12/28/2012
Based on the aggregated intelligence of 120,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, Chinese biotech 3SBio (Nasdaq: SSRX ) has earned a coveted five-star ranking. Our data has shown that five-star stocks ...
The Motley Fool · 12/11/2008
A number of stocks were upgraded by equities research analysts today, as reported by Analyst Ratings Network: Allegiant Travel (NASDAQ: ALGT) had its price target raised by analysts at Rodman & Renshaw from $72.00 to $79.00. They now have an …
Reuters · 7/13/2012
Forest Oil Corporation (NYSE: FST) 5.6% LOWER; today announced that it has commenced a registered underwritten public offering of 12,500,000 shares of its common stock. The underwriters ... www.streetinsider.com/entities/After-Hours+Movers.
StreetInsider · 5/19/2009